Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bridging the Continuous Glucose Monitoring decision gap: from glycaemic variability data to actionable stability in diabetes care.

Frontiers in endocrinology·2026
Same author

Amivantamab plus chemotherapy vs. chemotherapy as first-line treatment in Chinese mainland patients with EGFR exon 20 insertion non-small cell lung cancer: Subgroup analysis of the randomized PAPILLON trial.

Chinese medical journal·2026
Same author

[Retracted] Quercetin promotes the apoptosis of fibroblast‑like synoviocytes in rheumatoid arthritis by upregulating lncRNA MALAT1.

International journal of molecular medicine·2026
Same author

Effects of Cold and Sour Stimulation on Surface Electromyographic Signals of Swallowing Muscles in Healthy Young Adults.

Dysphagia·2026
Same author

A misdiagnosed case of tumefactive demyelinating lesion mimicking glioma: Imaging pitfalls and diagnostic lessons.

Radiology case reports·2026
Same author

A novel explainable deep-learning approach for network analysis of epistatic interactions.

NAR genomics and bioinformatics·2026

Related Experiment Video

Updated: May 21, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

TPH2 gene polymorphisms and major depression--a meta-analysis.

Jin Gao1, Zhenglun Pan, Zhian Jiao

  • 1Department of Medical Psychology, Shandong University School of Medicine, Jinan, Shandong, China.

Plos One
|June 14, 2012
PubMed
Summary
This summary is machine-generated.

This study investigated the link between TPH2 gene variations and major depressive disorder (MDD). A specific single nucleotide polymorphism (SNP), rs4570625, showed significant association with MDD, suggesting its potential role in the disorder.

More Related Videos

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
11:31

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

Related Experiment Videos

Last Updated: May 21, 2026

The Forced Swim Test as a Model of Depressive-like Behavior
05:42

The Forced Swim Test as a Model of Depressive-like Behavior

Published on: March 2, 2015

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
11:31

Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting

Published on: November 30, 2015

Area of Science:

  • Neuroscience
  • Genetics
  • Psychiatry

Background:

  • Tryptophan hydroxylase-2 (TPH2) is crucial for brain serotonin synthesis and central nervous system (CNS) serotonin transmission.
  • Gene-disease association studies suggest a link between TPH2 and major depressive disorder (MDD), but findings are inconsistent.

Purpose of the Study:

  • To conduct a systematic overview and meta-analysis of all available data on TPH2 and MDD.
  • To identify specific genetic variations within TPH2 associated with MDD.

Main Methods:

  • Systematic literature search of PubMed, Embase, HuGNet, and CNKI up to October 2011.
  • Meta-analysis of effect sizes for independent loci studied in over 3 articles using fixed and random effects models.
  • Inclusion of 27 eligible articles studying 74 single nucleotide polymorphisms (SNPs), with 12 independent loci meta-analyzed.

Main Results:

  • Two SNPs, rs4570625 and rs17110747, were associated with MDD.
  • SNP rs4570625 demonstrated low heterogeneity and remained significant under random effects models (OR=0.83, 95% CI: 0.73-0.96).

Conclusions:

  • The SNP rs4570625 exhibits strong epidemiological credibility for association with MDD.
  • Further research is needed to confirm other potential weak associations between TPH2 SNPs and MDD.